* indicates required



Explore Publications

Articles are listed from newest to oldest. Please pick an issue or industry area from the drop down menus to narrow your search.
Published by CorpWatch | By Pratap Chatterjee | Sunday, April 8, 2012

Johnson & Johnson has been fined $1.2 billion over sales of Risperdal, an antipsychotic drug. Tim Fox, a circuit judge in Arkansas, ruled that the company has to pay $5,000 for each of the 240,000 prescriptions that were paid for by the state's Medicaid program. (The program provides health care for low-income citizens, financed by the taxpayer)

Read More